All patient guidesSemua panduan pasien返回全部指南
March 04, 2026 Patient guidePanduan pasien就医指南

Cancer Treatment in Shanghai: A Guide for International PatientsCancer Treatment in Shanghai: A Guide for International Patients上海癌症治疗:国际患者指南

Shanghai has positioned itself as a leading hub for cancer treatment in Asia, attracting international patients with its blend of cutting-edge medical facilities, expert teams, and affordability. In 2026, the city offers access to innovativ…Shanghai has positioned itself as a leading hub for cancer treatment in Asia, attracting international patients with its blend of cutting-edge medical facilities, expert teams, and affordability. In 2026, the city offers access to innovativ…上海已成为亚洲癌症治疗的领先中心,以其尖端医疗设施、专业团队和经济实惠吸引国际患者。到2026年,该市提供创新疗法,如质子和重离子放疗、CAR-T细胞疗法和机器人手术,费用通常仅为西方价格的一小部分。凭借JCI认证的医院和专门的国际服务,上海将临床卓越与国际化环境相结合,使外国患者能够轻松获得医疗服务。

Shanghai has positioned itself as a leading hub for cancer treatment in Asia, attracting international patients with its blend of cutting-edge medical facilities, expert teams, and affordability. In 2026, the city offers access to innovative therapies like proton and heavy ion radiation, CAR-T cell therapy, and robotic surgery, often at a fraction of Western prices. With JCI-accredited hospitals and dedicated international services, Shanghai combines clinical excellence with a cosmopolitan environment, making it accessible for foreigners.

This guide summarizes key hospitals, treatment capabilities, approximate costs for international patients, and practical considerations to support your decision-making.

Why International Patients Choose Shanghai for Cancer Care

Shanghai's appeal stems from several factors:

  • Cost-Effective High-Quality Care: Treatments cost 20-50% less than in the US or Europe, with outcomes comparable to global standards—e.g., a 72% five-year survival rate for malignant tumors at top centers.
  • Rapid Access: Appointments and treatments can start within days, avoiding long waits common elsewhere.
  • Innovative Therapies: Home to the world's first high-volume proton/heavy ion center and leaders in CAR-T trials, Shanghai provides options for resistant or complex cases.
  • International Support: Many hospitals offer English-speaking staff, multilingual services, direct insurance billing (e.g., Cigna, Allianz), and visa assistance.
  • Clinical Trials: Extensive opportunities for free or low-cost access to new drugs and technologies.

Patients often seek Shanghai for second opinions, advanced radiation, or when costs at home are prohibitive.

Leading Oncology Hospitals in Shanghai

Shanghai's oncology landscape includes prestigious public research centers and private international hospitals.

  • Fudan University Shanghai Cancer Center (FUSCC): China's oldest specialized cancer hospital, leading in breast, lung, gastrointestinal, pancreatic, and other cancers. It features national key disciplines, MDT programs, and international research collaborations.

  • Shanghai Proton and Heavy Ion Center (SPHIC): The flagship for proton and carbon ion therapy, treating over 1,000 patients annually. Ideal for pediatric tumors, skull base, prostate, and tumors near critical organs, with 90%+ local control rates for certain cases.

  • Ruijin Hospital (Shanghai Jiao Tong University): Excels in hematologic malignancies (leukemia, lymphoma), liver cancer, and CAR-T therapy. Known for robotic surgery and over 500 pancreas resections.

  • Zhongshan Hospital (Fudan University): Renowned for liver cancer surgery, thoracic tumors, minimally invasive procedures, and liver transplantation in select cases.

  • Private and International-Focused Options:

  • Jiahui International Cancer Center: JCI-accredited, partnered with Massachusetts General Hospital. Offers Western-style care, rapid admission (same-day), and specialties in multidisciplinary oncology.
  • Shanghai GoBroad Hospital: Focuses on CAR-T and cell therapies for blood and solid tumors, with English support.
  • Renji Hospital: Strong in gastrointestinal and urological cancers, with advanced endoscopic techniques.
  • ParkwayHealth Shanghai International Hospital: Provides personalized services for expats, integrating Western and Chinese approaches.

Public hospitals emphasize research and volume, while private ones offer shorter waits and premium amenities.

Key Treatment Capabilities

Shanghai's hospitals deliver comprehensive, multidisciplinary care aligned with international protocols:

  • Multidisciplinary Teams (MDT): Standard for personalized plans involving surgeons, oncologists, radiologists, and geneticists.
  • Precision Diagnostics: NGS gene sequencing, molecular testing, and AI-driven pathology for targeted matching in lung, breast, and colorectal cancers.
  • Surgery: Robotic (Da Vinci), minimally invasive (laparoscopic, endoscopic), and cryoablation/NanoKnife for liver and lung tumors.
  • Chemotherapy & Targeted Therapy: Affordable domestic drugs with "chemo-free" options for advanced cases.
  • Immunotherapy: PD-1/PD-L1 inhibitors and combinations, often in trials.
  • Advanced Radiotherapy: IMRT, SBRT, and proton/carbon ion therapy—highly precise for resistant tumors like pancreatic or head/neck.
  • CAR-T Cell Therapy: Leading globally, with complete remission rates for blood cancers; emerging for solid tumors.
  • Integrative Traditional Chinese Medicine (TCM): Acupuncture and herbs to mitigate side effects, available at hybrid facilities.
  • Clinical Trials: Multi-center international studies providing free access to novel therapies.

High case volumes ensure expertise in complex and rare cancers.

Estimated Costs for International Patients (USD, 2026)

Costs vary by hospital, cancer stage, and treatment type; international patients often pay upfront but can use global insurance. Estimates are for private/international departments:

  • Initial Evaluation & Diagnostics: $2,000–$6,000 (consults, PET-CT, biopsies, genetic testing).
  • Surgery: $5,000–$35,000 (standard to robotic/complex).
  • Chemotherapy: $600–$3,500 per cycle; full course $6,000–$25,000.
  • Radiotherapy: $6,000–$18,000 (standard); $12,000–$30,000 (advanced); proton/heavy ion full course $40,000–$70,000.
  • Targeted/Immunotherapy: Monthly $2,500–$9,000; annual $30,000–$80,000.
  • CAR-T Therapy: $45,000–$300,000 (lower in public hospitals or trials).
  • Overall by Stage:
  • Early-stage (surgery + adjuvant): $8,000–$25,000.
  • Mid-stage comprehensive: $25,000–$50,000.
  • Advanced/maintenance (annual): $10,000–$30,000+.

Hospital stays: $30–$100/day (standard); $200–$600/day (VIP). Living costs: $70–$180/night (hotel); $1,000–$2,500/month (apartment). Trials can reduce expenses significantly.

Practical Advice for Foreign Patients

  • Prepare translated medical records (pathology, imaging, history) for reviews.
  • Obtain a medical (S2) visa with hospital invitations.
  • Book through international departments for language and insurance support.
  • Confirm insurance for direct billing; budget for deposits.
  • Enroll in trials if eligible to access free innovations.
  • Use telemedicine for follow-ups post-return.

Shanghai delivers innovative, high-quality cancer care in an international setting. Verify details with hospitals for personalized guidance. Best wishes for your health journey.

Shanghai has positioned itself as a leading hub for cancer treatment in Asia, attracting international patients with its blend of cutting-edge medical facilities, expert teams, and affordability. In 2026, the city offers access to innovative therapies like proton and heavy ion radiation, CAR-T cell therapy, and robotic surgery, often at a fraction of Western prices. With JCI-accredited hospitals and dedicated international services, Shanghai combines clinical excellence with a cosmopolitan environment, making it accessible for foreigners.

This guide summarizes key hospitals, treatment capabilities, approximate costs for international patients, and practical considerations to support your decision-making.

Why International Patients Choose Shanghai for Cancer Care

Shanghai's appeal stems from several factors:

  • Cost-Effective High-Quality Care: Treatments cost 20-50% less than in the US or Europe, with outcomes comparable to global standards—e.g., a 72% five-year survival rate for malignant tumors at top centers.
  • Rapid Access: Appointments and treatments can start within days, avoiding long waits common elsewhere.
  • Innovative Therapies: Home to the world's first high-volume proton/heavy ion center and leaders in CAR-T trials, Shanghai provides options for resistant or complex cases.
  • International Support: Many hospitals offer English-speaking staff, multilingual services, direct insurance billing (e.g., Cigna, Allianz), and visa assistance.
  • Clinical Trials: Extensive opportunities for free or low-cost access to new drugs and technologies.

Patients often seek Shanghai for second opinions, advanced radiation, or when costs at home are prohibitive.

Leading Oncology Hospitals in Shanghai

Shanghai's oncology landscape includes prestigious public research centers and private international hospitals.

  • Fudan University Shanghai Cancer Center (FUSCC): China's oldest specialized cancer hospital, leading in breast, lung, gastrointestinal, pancreatic, and other cancers. It features national key disciplines, MDT programs, and international research collaborations.

  • Shanghai Proton and Heavy Ion Center (SPHIC): The flagship for proton and carbon ion therapy, treating over 1,000 patients annually. Ideal for pediatric tumors, skull base, prostate, and tumors near critical organs, with 90%+ local control rates for certain cases.

  • Ruijin Hospital (Shanghai Jiao Tong University): Excels in hematologic malignancies (leukemia, lymphoma), liver cancer, and CAR-T therapy. Known for robotic surgery and over 500 pancreas resections.

  • Zhongshan Hospital (Fudan University): Renowned for liver cancer surgery, thoracic tumors, minimally invasive procedures, and liver transplantation in select cases.

  • Private and International-Focused Options:

  • Jiahui International Cancer Center: JCI-accredited, partnered with Massachusetts General Hospital. Offers Western-style care, rapid admission (same-day), and specialties in multidisciplinary oncology.
  • Shanghai GoBroad Hospital: Focuses on CAR-T and cell therapies for blood and solid tumors, with English support.
  • Renji Hospital: Strong in gastrointestinal and urological cancers, with advanced endoscopic techniques.
  • ParkwayHealth Shanghai International Hospital: Provides personalized services for expats, integrating Western and Chinese approaches.

Public hospitals emphasize research and volume, while private ones offer shorter waits and premium amenities.

Key Treatment Capabilities

Shanghai's hospitals deliver comprehensive, multidisciplinary care aligned with international protocols:

  • Multidisciplinary Teams (MDT): Standard for personalized plans involving surgeons, oncologists, radiologists, and geneticists.
  • Precision Diagnostics: NGS gene sequencing, molecular testing, and AI-driven pathology for targeted matching in lung, breast, and colorectal cancers.
  • Surgery: Robotic (Da Vinci), minimally invasive (laparoscopic, endoscopic), and cryoablation/NanoKnife for liver and lung tumors.
  • Chemotherapy & Targeted Therapy: Affordable domestic drugs with "chemo-free" options for advanced cases.
  • Immunotherapy: PD-1/PD-L1 inhibitors and combinations, often in trials.
  • Advanced Radiotherapy: IMRT, SBRT, and proton/carbon ion therapy—highly precise for resistant tumors like pancreatic or head/neck.
  • CAR-T Cell Therapy: Leading globally, with complete remission rates for blood cancers; emerging for solid tumors.
  • Integrative Traditional Chinese Medicine (TCM): Acupuncture and herbs to mitigate side effects, available at hybrid facilities.
  • Clinical Trials: Multi-center international studies providing free access to novel therapies.

High case volumes ensure expertise in complex and rare cancers.

Estimated Costs for International Patients (USD, 2026)

Costs vary by hospital, cancer stage, and treatment type; international patients often pay upfront but can use global insurance. Estimates are for private/international departments:

  • Initial Evaluation & Diagnostics: $2,000–$6,000 (consults, PET-CT, biopsies, genetic testing).
  • Surgery: $5,000–$35,000 (standard to robotic/complex).
  • Chemotherapy: $600–$3,500 per cycle; full course $6,000–$25,000.
  • Radiotherapy: $6,000–$18,000 (standard); $12,000–$30,000 (advanced); proton/heavy ion full course $40,000–$70,000.
  • Targeted/Immunotherapy: Monthly $2,500–$9,000; annual $30,000–$80,000.
  • CAR-T Therapy: $45,000–$300,000 (lower in public hospitals or trials).
  • Overall by Stage:
  • Early-stage (surgery + adjuvant): $8,000–$25,000.
  • Mid-stage comprehensive: $25,000–$50,000.
  • Advanced/maintenance (annual): $10,000–$30,000+.

Hospital stays: $30–$100/day (standard); $200–$600/day (VIP). Living costs: $70–$180/night (hotel); $1,000–$2,500/month (apartment). Trials can reduce expenses significantly.

Practical Advice for Foreign Patients

  • Prepare translated medical records (pathology, imaging, history) for reviews.
  • Obtain a medical (S2) visa with hospital invitations.
  • Book through international departments for language and insurance support.
  • Confirm insurance for direct billing; budget for deposits.
  • Enroll in trials if eligible to access free innovations.
  • Use telemedicine for follow-ups post-return.

Shanghai delivers innovative, high-quality cancer care in an international setting. Verify details with hospitals for personalized guidance. Best wishes for your health journey.

上海已成为亚洲癌症治疗的领先中心,以其尖端医疗设施、专业团队和经济实惠吸引国际患者。到2026年,该市提供创新疗法,如质子和重离子放疗、CAR-T细胞疗法和机器人手术,费用通常仅为西方价格的一小部分。凭借JCI认证的医院和专门的国际服务,上海将临床卓越与国际化环境相结合,使外国患者能够轻松获得医疗服务。

本指南总结了主要医院、治疗能力、国际患者的预计费用以及支持您决策的实用考虑事项。

为什么国际患者选择上海进行癌症护理

上海的吸引力源于多个因素:

  • 高性价比的优质护理:治疗费用比美国或欧洲低20-50%,疗效与全球标准相当——例如,顶级中心恶性肿瘤的五年生存率为72%。
  • 快速就医:预约和治疗可以在几天内开始,避免了其他地方常见的漫长等待。
  • 创新疗法:拥有全球首个高容量质子/重离子中心和CAR-T试验的领导者,上海为耐药或复杂病例提供了选择。
  • 国际支持:许多医院提供英语服务、多语言服务、直接保险结算(如Cigna、Allianz)和签证协助。
  • 临床试验:提供广泛的机会以低成本或免费获得新药和技术。

患者通常寻求上海的第二意见、先进的放疗,或在家中费用过高时前来就医。

上海领先的肿瘤医院

上海的肿瘤学领域包括著名的公共研究中心和私立国际医院。

  • 复旦大学上海癌症中心(FUSCC):中国最古老的专科癌症医院,在乳腺癌、肺癌、胃肠道癌症、胰腺癌等方面处于领先地位。它拥有国家重点学科、MDT项目和国际研究合作。

  • 上海质子与重离子中心(SPHIC):质子和碳离子治疗的旗舰,每年治疗超过1000名患者。适用于儿童肿瘤、颅底、前列腺和靠近重要器官的肿瘤,某些病例的局部控制率超过90%。

  • 瑞金医院(上海交通大学):在血液恶性肿瘤(白血病、淋巴瘤)、肝癌和CAR-T疗法方面表现出色。以机器人手术和超过500例胰腺切除术而闻名。

  • 中山医院(复旦大学):以肝癌手术、胸部肿瘤、微创手术和选择性肝移植而闻名。

  • 私立和国际化选择:

  • 嘉会国际癌症中心:JCI认证,与麻省总医院合作。提供西式护理、快速入院(同日)和多学科肿瘤学专业。
  • 上海广博医院:专注于血液和实体肿瘤的CAR-T和细胞疗法,提供英语支持。
  • 仁济医院:在胃肠道和泌尿系统癌症方面表现强劲,拥有先进的内窥镜技术。
  • 上海国际医院(ParkwayHealth):为外籍人士提供个性化服务,结合西方和中国的方法。

公立医院强调研究和病例量,而私立医院则提供更短的等待时间和优质设施。

主要治疗能力

上海的医院提供全面的多学科护理,符合国际标准:

  • 多学科团队(MDT):个性化计划的标准,涉及外科医生、肿瘤科医生、放射科医生和遗传学家。
  • 精准诊断:NGS基因测序、分子检测和人工智能驱动的病理学,针对肺癌、乳腺癌和结直肠癌进行靶向匹配。
  • 手术:机器人手术(达芬奇)、微创手术(腹腔镜、内窥镜)和冷冻消融/NanoKnife用于肝脏和肺部肿瘤。
  • 化疗和靶向治疗:经济实惠的国内药物,针对晚期病例提供“无化疗”选项。
  • 免疫疗法:PD-1/PD-L1抑制剂及其组合,通常在临床试验中。
  • 先进放疗:IMRT、SBRT和质子/碳离子治疗——对耐药肿瘤(如胰腺或头颈部肿瘤)具有高度精确性。
  • CAR-T细胞疗法:在全球领先,血液癌症的完全缓解率;在实体肿瘤中逐渐应用。
  • 综合传统中医(TCM):针灸和草药以减轻副作用,混合设施提供。
  • 临床试验:多中心国际研究提供免费获得新疗法的机会。

高病例量确保在复杂和罕见癌症方面的专业知识。

国际患者的预计费用(美元,2026年)

费用因医院、癌症阶段和治疗类型而异;国际患者通常需提前支付,但可以使用全球保险。以下是私立/国际部门的估算:

  • 初步评估和诊断:$2,000–$6,000(咨询、PET-CT、活检、基因检测)。
  • 手术:$5,000–$35,000(标准到机器人/复杂)。
  • 化疗:每周期$600–$3,500;完整疗程$6,000–$25,000。
  • 放疗:$6,000–$18,000(标准);$12,000–$30,000(高级);质子/重离子完整疗程$40,000–$70,000。
  • 靶向/免疫疗法:每月$2,500–$9,000;每年$30,000–$80,000。
  • CAR-T疗法:$45,000–$300,000(公立医院或临床试验中费用较低)。
  • 按阶段的整体费用:
  • 早期阶段(手术+辅助治疗):$8,000–$25,000。
  • 中期综合治疗:$25,000–$50,000。
  • 晚期/维持治疗(每年):$10,000–$30,000+。

住院费用:$30–$100/天(标准);$200–$600/天(VIP)。生活费用:$70–$180/晚(酒店);$1,000–$2,500/月(公寓)。临床试验可以显著降低费用。

外国患者的实用建议

  • 准备翻译的医疗记录(病理、影像、病史)以供审核。
  • 获取医疗(S2)签证,附医院邀请函。
  • 通过国际部门预约,以获得语言和保险支持。
  • 确认保险以便直接结算;预算存款。
  • 如果符合条件,报名参加临床试验以获得免费创新。
  • 返回后使用远程医疗进行随访。

上海在国际环境中提供创新的高质量癌症护理。请与医院核实详细信息以获得个性化指导。祝您健康之旅顺利。

WhatsApp